BRIEF-Emergent Biosolutions initiates Niaid-funded phase 1B clinical study
* Emergent Biosolutions initiates Niaid-funded phase 1B clinical study to evaluate broad-spectrum antiviral UV-4B for dengue [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: study, phase, Niaid-funded, initiates, Biosolutions, for dengue, UV-4B, antiviral, broad-spectrum, evaluate, 1B clinical, Emergent, clinical, BRIEF-Emergent
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/CpOJvQWu1Eo/idUSFWN1FM0PG